menu search

New Study Confirms Consistent Risk of Myelosuppression Across All Patients Receiving Chemotherapy for Small Cell Lung Cancer

New Study Confirms Consistent Risk of Myelosuppression Across All Patients Receiving Chemotherapy for Small Cell Lung Cancer
Real-World Data Show No Association Between Patient Characteristics and Risk of Myelosuppressive Events RESEARCH TRIANGLE PARK, N.C., May 16, 2023 (GLOBE NEWSWIRE) — G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today described recently presented real-world data that confirm a consistent risk of myelosuppressive events (neutropenia, anemia, thrombocytopenia) across patients with small cell lung […] The post New Study Confirms Consistent Risk of Myelosuppression Acros... Read More
Posted: May 16 2023, 11:30
Author Name: forextv
Views: 110432

Search within

Pages Search Results: